| [1] |
Koppikar A M, Wu C, Leavena T , et al. Health assessment of 1,3-butadiene, EPA/600/P-98/001F [EB/OL]. [ 2017- 05- 09]. .
|
| [2] |
US EPA. 1,3-Butadiene, CASRN 106-99-0 [EB/OL]. [ 2017- 05- 09]. .
|
| [3] |
US EPA. Benzene, CASRN 71-43-2 [EB/OL]. [ 2017- 05- 09]. .
|
| [4] |
Loh M M, Levy J I, Spengler J D , et al. Ranking cancer risks of organic hazardous air pollutants in the United States[J]. Environ Health Perspect, 2007,115(8):1160-1168.
|
| [5] |
McCarthy M C, O'brien T E, Charrier J G , et al. Characterization of the chronic risk and hazard of hazardous air pollutants in the United States using ambient monitoring data[J]. Environ Health Perspect, 2009,117(5):790-796.
|
| [6] |
Zhou J, You Y, Bai Z , et al. Health risk assessment of personal inhalation exposure to volatile organic compounds in Tianjin, China[J]. Sci Total Environ, 2011,409(3):452-459.
|
| [7] |
Du Z, Mo J, Zhang Y . Risk assessment of population inhalation exposure to volatile organic compounds and carbonyls in urban China[J]. Environ Int, 2014,73:33-45.
|
| [8] |
Fowles J, Dybing E . Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke[J]. Tob Control, 2003,12(4):424-430.
|
| [9] |
Sleiman M, Logue J M, Luo W , et al. Inhalable constituents of thirdhand tobacco smoke: chemical characterization and health impact considerations[J]. Environ Sci Technol, 2014,48(22):13093-13101.
|
| [10] |
Zhang X Y, Elfarra A A . Potential roles of myeloperoxidase and hypochlorous acid in metabolism and toxicity of alkene hydrocarbons and drug molecules containing olefinic moieties[J]. Expert Opin Drug Metab Toxicol, 2017,13(5):513-524.
|
| [11] |
Duescher R J, Elfarra A A . 1,3-Butadiene oxidation by human myeloperoxidase[J]. J Biol Chem, 1992,267(28):19859-19865.
|
| [12] |
Elfarra A A, Zhang X Y . Alcohol dehydrogenase- and rat liver cytosol-dependent bioactivation of 1-chloro-2-hydroxy-3-butene to 1-chloro-3-buten-2-one, a bifunctional alkylating agent[J]. Chem Res Toxicol, 2012,25(11):2600-2607.
|
| [13] |
Sun L, Pelah A, Zhang D P , et al. Formation of fused-ring 2-deoxycytidine adducts from 1-chloro-3-buten-2-one, an in vitro 1,3-butadiene metabolite, under in vitro physiological conditions[J]. Chem Res Toxicol, 2013,26(10):1545-1553.
|
| [14] |
Zheng J, Li Y, Yu Y X , et al. Novel adducts from the reaction of 1-chloro-3-buten-2-one with 2-deoxyguanosine. Structural characterization and potential as tools to investigate 1,3-butadiene carcinogenicity[J]. Chem Biol Interact, 2015,226:40-48.
|
| [15] |
Zeng F M, Liu L Y, Zheng J , et al. Identification of a fused-ring 2-deoxyadenosine adduct formed in human cells incubated with 1-chloro-3-buten-2-one, a potential reactive metabolite of 1,3-butadiene[J]. Chem Res Toxicol, 2016,29(6):1041-1059.
|
| [16] |
Liu L Y, Zheng J, Kong C , et al. Characterization of the major purine and pyrimidine adducts formed after incubations of 1-chloro-3-buten-2-one with single-/double-stranded DNA and human cells[J]. Chem Res Toxicol, 2017,30(2):552-563.
|
| [17] |
Liu X J, Zeng F M, An J , et al. Cytotoxicity, genotoxicity, and mutagenicity of 1-chloro-2-hydroxy-3- butene and 1-chloro-3-buten-2-one, two alternative metabolites of 1,3-butadiene[J]. Toxicol Appl Pharmacol, 2013,271(1):13-19.
|
| [18] |
Wen Y, Zhang P P, An J , et al. Diepoxybutane induces the formation of DNA-DNA rather than DNA-protein cross-links, and single-strand breaks and alkali-labile sites in human hepatocyte L02 cells[J]. Mutat Res, 2011,716(1/2):84-91.
|
| [19] |
Zhang P P, Wen Y, An J , et al. DNA damage induced by three major metabolites of 1,3-butadiene in human hepatocyte L02 cells[J]. Mutat Res, 2012,747(2):240-245.
|
| [20] |
Lea M A . Regulation of gene expression in hepatomas[J]. Int J Biochem, 1993,25(4):457-469.
|
)
